99 related articles for article (PubMed ID: 6707948)
1. Stereoselectivity of S- and R-sulpiride for pre- and postsynaptic dopamine receptors in the canine kidney.
Bass AS; Robie NW
J Pharmacol Exp Ther; 1984 Apr; 229(1):67-71. PubMed ID: 6707948
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
Grega GJ; Barrett RJ; Adamski SW; Lokhandwala MF
J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
[TBL] [Abstract][Full Text] [Related]
4. Attenuation by arachidonic acid of the effect of vasoconstrictor stimuli in the canine kidney.
Susić H; Malik KU
J Pharmacol Exp Ther; 1981 Nov; 219(2):377-82. PubMed ID: 6793715
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
Itoh H; Kohli JD; Rajfer SI; Goldberg LI
J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
[TBL] [Abstract][Full Text] [Related]
6. Facilitation of ganglionic transmission by sulpiride: evidence for an inhibitory role of dopamine in the canine sympathetic ganglion.
Horn PT; Kohli JD; Goldberg LI
J Pharmacol Exp Ther; 1982 Nov; 223(2):462-8. PubMed ID: 6290639
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
8. Prostacyclin and prostaglandin E2 effects on adrenergic transmission in the kidney of anesthetized dog.
Susić H; Malik KU
J Pharmacol Exp Ther; 1981 Sep; 218(3):588-92. PubMed ID: 6167710
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
[TBL] [Abstract][Full Text] [Related]
10. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
Hom GJ; Jandhyala BS
J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic dopamine receptor stimulation in the cardiovascular actions of lergotrile.
Barrett RJ; Lokhandwala MF
J Pharmacol Exp Ther; 1981 Jun; 217(3):660-5. PubMed ID: 6112262
[TBL] [Abstract][Full Text] [Related]
12. [Sulpiride (stereoisomers, racemic) and dopamine: actions and interactions on renal circulation].
Agnoli GC; Andreone P; Cacciari M; Garutti C; Ikonomu E; Lenzi P
Boll Soc Ital Biol Sper; 1984 Jan; 60(1):169-74. PubMed ID: 6704243
[TBL] [Abstract][Full Text] [Related]
13. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
Kohli JD; Goldberg LI; Volkman PH; Cannon JG
J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
[TBL] [Abstract][Full Text] [Related]
14. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
Goldberg LI; Kohli JD; Cantacuzene D; Kirk KL; Creveling CR
J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
[TBL] [Abstract][Full Text] [Related]
15. Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.
Listinsky JJ; Kohli JD; Goldberg LI
J Pharmacol Exp Ther; 1980 Dec; 215(3):662-7. PubMed ID: 6108364
[TBL] [Abstract][Full Text] [Related]
16. [Sulpiride and the effect of dopamine on the kidney in human salt retention].
Agnoli GC; Cacciari M; Garutti C; Lenzi P
Boll Soc Ital Biol Sper; 1979 Feb; 55(4):311-7. PubMed ID: 552845
[TBL] [Abstract][Full Text] [Related]
17. Primate cardiovascular responses mediated by dopamine receptors: effects of N,N-di-n-propyldopamine and LY171555.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1984 Apr; 229(1):132-8. PubMed ID: 6707929
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
Lokhandwala MF; Kivlighn SD; Jandhyala BS
J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
[TBL] [Abstract][Full Text] [Related]
19. Peripheral dopamine receptors.
Clark BJ; Menninger K
Circ Res; 1980 Jun; 46(6 Pt 2):I59-63. PubMed ID: 6991152
[TBL] [Abstract][Full Text] [Related]
20. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
DiBona GF; Sawin LL
J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
